Peripheral T-cell lymphomas unspecified presenting in the skin: analysis of prognostic factors in a group of 82 patients
Authors:
- Maarten H. VermeerMaarten H. Vermeer
- Patty M. JansenPJPatty M. Jansen
- Ariënne M. W. van MarionAMAriënne M. W. van Marion
- Marijke R. Canninga-Van DijkMDMarijke R. Canninga-Van Dijk
- Philip M. KluinPKPhilip M. Kluin
- Marie-Louise GeertsMGMarie-Louise Geerts
- Chris J. L. M. MeijerCMChris J. L. M. Meijer
- Rein WillemzeRWRein Willemze
- 15 September 2003
- journal article
- Published by American Society of Hematology in Blood
- Vol. 102 (6) , 2213-2219
Abstract
In the present study the clinicopathologic and immunophenotypic features of 82 patients with a CD30– peripheral T-cell lymphoma, unspecified, presenting in the skin were evaluated. The purpose of this study was to find out whether subdivision of these lymphomas on the basis of cell size, phenotype, or presentation with only skin lesions is clinically relevant. The study group included 46 primary cutaneous CD30– large cell lymphomas and 17 small/medium-sized T-cell lymphomas as well as 17 peripheral T-cell lymphomas with both skin and extracutaneous disease at the time of diagnosis. Patients with primary cutaneous small- or medium-sized T-cell lymphomas had a significantly better prognosis (5-year-overall survival, 45%) than patients with primary cutaneous CD30– large T-cell lymphomas (12%) and patients presenting with concurrent extracutaneous disease (12%). The favorable prognosis in this group with primary cutaneous small- or medium-sized T-cell lymphomas was particularly found in patients presenting with localized skin lesions expressing a CD3+CD4+CD8– phenotype. In the primary cutaneous T-cell lymphoma (CTCL) group and in the concurrent group, neither extent of skin lesions nor phenotype had any effect on survival. Our results indicate that peripheral T-cell lymphomas, unspecified, presenting in the skin have an unfavorable prognosis, irrespective of the presence or absence of extracutaneous disease at the time of diagnosis, cell size, and expression of a CD4+ or CD8+ phenotype. The only exception was a group of primary cutaneous small- or medium-sized pleomorphic CTCLs with a CD3+CD4+CD8– phenotype and presenting with localized skin lesions.Keywords
This publication has 8 references indexed in Scilit:
- Primary cutaneous lymphomas: applicability of current classification schemes (European Organization for Research and Treatment of Cancer, World Health Organization) based on clinicopathologic features observed in a large group of patientsBlood, 2002
- Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin’s Lymphoma Classification ProjectAnnals of Oncology, 2002
- Primary Cutaneous CD8-Positive Epidermotropic Cytotoxic T Cell LymphomasThe American Journal of Pathology, 1999
- Peripheral T-cell lymphomas: Initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. ClassificationAnnals of Oncology, 1998
- Differences in Epstein-Barr Virus Expression Between Primary and Secondary Cutaneous Angiocentric LymphomasArchives of Dermatology, 1998
- A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's LymphomaBlood, 1997
- Primary cutaneous T‐cell lymphoma: Clinicopathological features and prognostic parameters of 35 cases other than mycosis fungoides and cd30‐positive large cell lymphomaThe Journal of Pathology, 1994
- Cutaneous pseudo-T-cell lymphomas. A clinicopathologic study of 20 patientsCancer, 1992